Prometheus Biosciences
$9.55 B
Share price
Change (1 day)
Change (1 year)

Prometheus Biosciences (RXDX) - Cash on Hand

Cash on Hand as of March 2023 : $0.71 B

According to Prometheus Biosciences's latest financial reports the company has $0.71 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Prometheus Biosciences - Cash on Hand chart (from 2020 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$0.69 B170.45%
2021-12-31$0.25 B374.63%
2020-12-31$54.2 M1118%
2019-12-31$4.45 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$56.95 M-92.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.15 B-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA